Clinical Trial Update: Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 vaccination study of abatacept (BMS-188667) in healthy volunteers has completed. The study is related to rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED